Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-28 @ 7:33 AM
Study NCT ID:
NCT04912466
Status:
COMPLETED
Last Update Posted:
2023-09-06
First Post:
2021-05-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IBI322 Monotherapy or Combination Therapy in Subjects With Advanced Malignant Tumors.
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-25
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-28
First Submit QC Date:
None
Study First Post Date:
2021-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-04
Last Update Post Date:
2023-09-06
Last Update Post Date Type:
ACTUAL